Medical Aspects of Chemical Warfare (2008) - The Black Vault

Neuroprotection as a Treatment for Nerve Agent Survivors158. Ubogu EE, Sagar SM, Lerner AJ, Maddux BN, Suarez JI, Werz MA. Ketamine for refractory status epilepticus: a caseof possible ketamine-induced neurotoxicity. Epilepsy Behav. 2003;4:70–75.159. Wolff K, Winstock AR. Ketamine: from medicine to misuse. CNS Drugs. 2006;20:199–218.160. Pazdernik TL, Emerson MR, Cross R, Nelson SR, Samson FE. Soman-induced seizures: limbic activity, oxidative stressand neuroprotective proteins. J Appl Toxicol. 2001:21(suppl 1):S87–S94.161. Pagni CA, Zenga F. Posttraumatic epilepsy with special emphasis on prophylaxis and prevention. Acta Neurochir Suppl.2005;93:27–34.162. Yokoi I, Toma J, Liu J, Kabuto H, Mori A. Adenosines scavenged hydroxyl radicals and prevented posttraumaticepilepsy. Free Radic Biol Med. 1995;19:473–479.163. Davies KJ. Oxidative stress: the paradox of aerobic life. Biochem Soc Symp. 1995;61:1–31.164. Zivin M, Milatovic D, Dettbarn WD. Nitrone spin trapping compound N-tert-butyl-alpha-phenylnitrone preventsseizures induced by anticholinesterases. Brain Res. 1999;850:63–72.165. Peterson SL, Purvis RS, Griffith JW. Comparison of neuroprotective effects induced by alpha-phenyl-N-tert-butylnitrone (PBN) and N-tert-butyl-alpha-(2 sulfophenyl) nitrone (S-PBN) in lithium-pilocarpine status epilepticus. Neurotoxicology.2005;26:969–979.166. Cao X, Phillis JW. Alpha-Phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia.Brain Res. 1994;644:267–272.167. Meyerhoff JL. Division of Neurosciences, Walter Reed Army Institute of Research, Silver Spring, Md 20910-7500, USA.Personal communication with Newmark J, March 2006.168. Lockhart B, Roger A, Bonhomme N, Goldstein S, Lestage P. In vivo neuroprotective effects of the novel imidazolylnitrone free-radical scavenger (Z)-alpha-[2-thiazol-2-yl)imidazol-4-yl]-N-tert-butylnitrone (S34176). Eur J Pharmacol.2005;511:127–136.169. Bauman RA, Yourick DL, Wessner K, et al. A model for studying neuroprotection from seizure-induced brain injuryresulting from exposure to organophosphate (OP) nerve agents. In: Proceedings of the NATO Task Group on Prophylaxisand Therapy Against Chemical Agents; May 23–27, 2005. Hradec Kralove, Czech Republic.170. Kudin AP, Debska-Vielhaber G, Vielhaber S, Elger CE, Kunz WS. The mechanism of neuroprotection by topiramatein an animal model of epilepsy. Epilepsia. 2004;45:1478–1487.171. Setkowicz Z, Ciarach M, Guzik R, Janeczko K. Different effects of neuroprotectants FK-506 and cyclosporin A on susceptibilityto pilocarpine-induced seizures in rats with brain injured at different developmental stages. Epilepsy Res.2004;61:63–72.172. Santos JB, Schauwecker PE. Protection provided by cyclosporin A against excitotoxic neuronal death is genotypedependent. Epilepsia. 2003;44:995–1002173. Okonkwo DO, Melon DE, Pellicane AJ, et al. Dose-response of cyclosporin A in attenuating traumatic axonal injuryin rat. Neuroreport. 2003;14:463–466.174. Friberg H, Wieloch T. Mitochondrial permeability transition in acute neurodegeneration. Biochimie. 2002;84:241–250.175. De Keyser J, Uyttenboogaart M, Koch MW, et al. Neuroprotection in acute ischemic stroke. Acta Neurol Belg.2005;105:144–148.176. Li J, Luan X, Lai Q, et al. Long-term neuroprotection induced by regional brain cooling with saline infusion into ischemicterritory in rats: a behavioral analysis. Neurol Res. 2004;26:677–683.241